Roche Diagnostics · Class II · Cleared Apr 26, 2024
| K-number | K220272 |
| Device name | cobas pulse blood glucose monitoring system |
| Applicant | Roche Diagnostics |
| Product code | PZI |
| Device class | Class II |
| Decision date | Apr 26, 2024 |
| Decision | Substantially Equivalent |
| Regulation | 862.1345 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov